EUVIMEDEUVIMED entdecken
Multizentrische Studie

Different Approaches to Atrial Fibrillation Ablation in Heart Failure Patients

Marco Bergonti, Philipp Krisai, Ciro Ascione, Thomas Pambrun, Domenico G Della Rocca, Paolo Compagnucci, Tardu Özkartal, Lorenzo Marcon, Teba Gonzalez Ferrero, Luigi Pannone, Michael Kühne, Matteo Anselmino und 14 weitere

JACC: Clinical Electrophysiology · 2025-05 · 11 (5) · 942-952

DOI: 10.1016/j.jacep.2024.12.004 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JACC: Clinical Electrophysiology, 2025-05. Verfasst von Marco Bergonti und 25 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Cardiocentro Ticino Institute, Lugano, Switzerland. Electronic address: bergmar21@gmail.com. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation, Heart Failure. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Catheter ablation of atrial fibrillation has been proven beneficial in patients with heart failure and reduced ejection fraction (HFrEF). On top of pulmonary vein isolation (PVI), additional ablation strategies such as empirical lines/posterior box/low voltage ablation (PVI+L/LVA) are often used. Whether PVI+L/LVA provides additional benefits in this population has never been systematically investigated. OBJECTIVES: This study sought to analyze the temporal trends and comparative outcomes of PVI+L/LVA vs PVI alone. METHODS: Patients with HFrEF undergoing atrial fibrillation ablation were retrospectively enrolled. The 2 coprimary endpoints were ventricular function recovery and atrial fibrillation recurrence-free survival at 1 year. The performance of PVI and PVI+L/LVA was compared in the overall population and in 2 matched groups. A sensitivity analysis for measured confounders was performed. RESULTS: A total of 955 HFrEF patients (age 62.1 years, 24.4% female) from 9 international centers were included (PVI only 51.6% vs PVI+L/LVA 48.4%). At 12 months after the procedure, 62.3% of the patients remained free from arrhythmia recurrences and 65.4% experienced ventricular function recovery. Comparing PVI to PVI+L/LVA, no significant difference in the 2 coprimary endpoints was observed, neither in the overall nor in the matched cohorts. The use of PVI+L/LVA increased from 27% in 2013 to 68% in 2022. Patients undergoing PVI+L/LVA experienced more complications (3.8 vs 1.2%; P = 0.018). CONCLUSIONS: Catheter ablation is associated with significant improvements in systolic function, irrespective of the ablation strategy used. The use of PVI+L/LVA in HFrEF patients is progressively expanding over time. Although the benefits of this practice remain unproven, it is associated with an increased risk of overall and nonvascular complications. These results warrant caution regarding the growing use of PVI+ in HFrEF patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCatheter AblationHeart FailureHumansFemaleMaleMiddle AgedRetrospective StudiesAgedTreatment OutcomePulmonary VeinsStroke VolumeRecurrence

Stichwörter der Autor:innen

AF ablationPVI plusatrial fibrillationheart failurepulmonary vein isolationrecoveryreduced ejection fraction

Autor:innen und Institutionen

  • Division of Cardiology, Cardiocentro Ticino Institute, Lugano, Switzerland. Electronic address: bergmar21@gmail.com.
  • Cardiology Division, Cardiovascular Research Institute Basel, University Hospital Basel, Basel, Switzerland.
  • Division of Cardiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
  • Electrophysiology and Ablation Unit, Hospital Haut-Lévêque, Centre Hospitalier Universitaire de Bordeaux, University of Bordeaux, Bordeaux, France; L'Institut de Rythmologie et Modélisation Cardiaque, Université de Bord…
  • Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, European Reference Networks Guard-Heart, Brussels, Belgium; Card…
  • Cardiology and Arrhythmology Clinic, University Hospital "Ospedali Riuniti Umberto I-Lancisi-Salesi," Università Politecnica delle Marche, Ancona, Italy.

Zitieren

APA

Bergonti, M., Krisai, P., Ascione, C., Pambrun, T., Della Rocca, D. G., Compagnucci, P., Özkartal, T., Marcon, L., Ferrero, T. G., Pannone, L., Kühne, M., Anselmino, M., Casella, M., Serban, T., Tondo, C., Rodríguez-Mañero, M., Caputo, M. L., Badertscher, P., Derval, N., …, & Conte, G. (2025). Different Approaches to Atrial Fibrillation Ablation in Heart Failure Patients. JACC: Clinical Electrophysiology, 11(5), 942-952. https://doi.org/10.1016/j.jacep.2024.12.004

Vancouver

Bergonti M, Krisai P, Ascione C, Pambrun T, Della Rocca DG, Compagnucci P, et al. Different Approaches to Atrial Fibrillation Ablation in Heart Failure Patients. JACC: Clinical Electrophysiology. 2025;11(5):942-952. doi:10.1016/j.jacep.2024.12.004

BibTeX
@article{Bergonti2025,
  author = {Bergonti, Marco and Krisai, Philipp and Ascione, Ciro and Pambrun, Thomas and Della Rocca, Domenico G and Compagnucci, Paolo and Özkartal, Tardu and Marcon, Lorenzo and Ferrero, Teba Gonzalez and Pannone, Luigi and Kühne, Michael and Anselmino, Matteo and Casella, Michela and Serban, Teodor and Tondo, Claudio and Rodríguez-Mañero, Moises and Caputo, Maria Luce and Badertscher, Patrick and Derval, Nicolas and de Asmundis, Carlo and Chierchia, Gian Battista and Heidbuchel, Hein and Jaïs, Pierre and Auricchio, Angelo and Sarkozy, Andrea and Conte, Giulio},
  title = {Different Approaches to Atrial Fibrillation Ablation in Heart Failure Patients},
  journal = {JACC: Clinical Electrophysiology},
  year = {2025},
  volume = {11},
  number = {5},
  pages = {942--952},
  doi = {10.1016/j.jacep.2024.12.004}
}
Kostenlos starten →